1. EXECUTIVE SUMMARY1.1. Market Overview1.2. Key Findings1.3. Market Segmentation1.4. Competitive Landscape1.5. Challenges and Opportunities1.6. Future Outlook2. MARKET INTRODUCTION2.1. Definition2.2. Scope of the study2.2.1. Research Objective2.2.2. Assumption2.2.3. Limitations3. RESEARCH METHODOLOGY3.1. Overview3.2. Data Mining3.3. Secondary Research3.4. Primary Research3.4.1. Primary Interviews and Information Gathering Process3.4.2. Breakdown of Primary Respondents3.5. Forecasting Model3.6. Market Size Estimation3.6.1. Bottom-Up Approach3.6.2. Top-Down Approach3.7. Data Triangulation3.8. Validation
4. MARKET DYNAMICS4.1. Overview4.2. Drivers4.3. Restraints4.4. Opportunities5. MARKET FACTOR ANALYSIS5.1. Value chain Analysis5.2. Porter's Five Forces Analysis5.2.1. Bargaining Power of Suppliers5.2.2. Bargaining Power of Buyers5.2.3. Threat of New Entrants5.2.4. Threat of Substitutes5.2.5. Intensity of Rivalry5.3. COVID-19 Impact Analysis5.3.1. Market Impact Analysis5.3.2. Regional Impact5.3.3. Opportunity and Threat Analysis6. RADIOPHARMACEUTICALS MARKET, BY APPLICATION (USD BILLION)6.1. Diagnosis6.2. Therapy6.3. Research7. RADIOPHARMACEUTICALS MARKET, BY TYPE (USD BILLION)7.1. Diagnostic Radiopharmaceuticals7.2. Therapeutic Radiopharmaceuticals8. RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS (USD BILLION)8.1. Radioisotopes8.2. Radiolabeled Compounds8.3. Radiopharmaceutical Generators9. RADIOPHARMACEUTICALS MARKET, BY END USE (USD BILLION)9.1. Hospitals9.2. Diagnostic Imaging Centers9.3. Research Institutions10. RADIOPHARMACEUTICALS MARKET, BY REGIONAL (USD BILLION)10.1. North America10.1.1. US10.1.2. Canada10.2. Europe10.2.1. Germany10.2.2. UK10.2.3. France10.2.4. Russia10.2.5. Italy10.2.6. Spain10.2.7. Rest of Europe10.3. APAC10.3.1. China10.3.2. India10.3.3. Japan10.3.4. South Korea10.3.5. Malaysia10.3.6. Thailand10.3.7. Indonesia10.3.8. Rest of APAC10.4. South America10.4.1. Brazil10.4.2. Mexico10.4.3. Argentina10.4.4. Rest of South America10.5. MEA10.5.1. GCC Countries10.5.2. South Africa10.5.3. Rest of MEA11. COMPETITIVE LANDSCAPE11.1. Overview11.2. Competitive Analysis11.3. Market share Analysis11.4. Major Growth Strategy in the Radiopharmaceuticals Market11.5. Competitive Benchmarking11.6. Leading Players in Terms of Number of Developments in the Radiopharmaceuticals Market11.7. Key developments and growth strategies11.7.1. New Product Launch/Service Deployment11.7.2. Merger & Acquisitions11.7.3. Joint Ventures11.8. Major Players Financial Matrix11.8.1. Sales and Operating Income11.8.2. Major Players R&D Expenditure. 202312. COMPANY PROFILES12.1. Northstar Medical Radioisotopes12.1.1. Financial Overview12.1.2. Products Offered12.1.3. Key Developments12.1.4. SWOT Analysis12.1.5. Key Strategies12.2. Bracco Imaging12.2.1. Financial Overview12.2.2. Products Offered12.2.3. Key Developments12.2.4. SWOT Analysis12.2.5. Key Strategies12.3. Nordion12.3.1. Financial Overview12.3.2. Products Offered12.3.3. Key Developments12.3.4. SWOT Analysis12.3.5. Key Strategies12.4. Advanced Accelerator Applications12.4.1. Financial Overview12.4.2. Products Offered12.4.3. Key Developments12.4.4. SWOT Analysis12.4.5. Key Strategies12.5. United Imaging Healthcare12.5.1. Financial Overview12.5.2. Products Offered12.5.3. Key Developments12.5.4. SWOT Analysis12.5.5. Key Strategies12.6. Lantheus12.6.1. Financial Overview12.6.2. Products Offered12.6.3. Key Developments12.6.4. SWOT Analysis12.6.5. Key Strategies12.7. GE Healthcare12.7.1. Financial Overview12.7.2. Products Offered12.7.3. Key Developments12.7.4. SWOT Analysis12.7.5. Key Strategies12.8. Cleveland Clinic12.8.1. Financial Overview12.8.2. Products Offered12.8.3. Key Developments12.8.4. SWOT Analysis12.8.5. Key Strategies12.9. Novartis12.9.1. Financial Overview12.9.2. Products Offered12.9.3. Key Developments12.9.4. SWOT Analysis12.9.5. Key Strategies12.10. Telix Pharmaceuticals12.10.1. Financial Overview12.10.2. Products Offered12.10.3. Key Developments12.10.4. SWOT Analysis12.10.5. Key Strategies12.11. Bayer12.11.1. Financial Overview12.11.2. Products Offered12.11.3. Key Developments12.11.4. SWOT Analysis12.11.5. Key Strategies12.12. Elekta12.12.1. Financial Overview12.12.2. Products Offered12.12.3. Key Developments12.12.4. SWOT Analysis12.12.5. Key Strategies12.13. Cardinal Health12.13.1. Financial Overview12.13.2. Products Offered12.13.3. Key Developments12.13.4. SWOT Analysis12.13.5. Key Strategies12.14. Siemens Healthineers12.14.1. Financial Overview12.14.2. Products Offered12.14.3. Key Developments12.14.4. SWOT Analysis12.14.5. Key Strategies12.15. Itheon Pharmaceuticals12.15.1. Financial Overview12.15.2. Products Offered12.15.3. Key Developments12.15.4. SWOT Analysis12.15.5. Key Strategies13. APPENDIX13.1. References13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONSTABLE 2. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 3. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 4. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 5. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 6. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 7. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 8. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 9. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 10. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 11. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 12. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 13. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 14. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 15. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 16. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 17. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 18. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 19. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 20. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 21. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 22. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 23. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 24. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 25. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 26. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 27. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 28. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 29. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 30. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 31. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 32. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 33. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 34. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 35. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 36. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 37. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 38. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 39. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 40. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 41. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 42. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 43. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 44. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 45. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 46. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 47. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 48. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 49. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 50. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 51. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 52. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 53. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 54. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 55. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 56. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 57. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 58. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 59. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 60. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 61. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 62. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 63. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 64. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 65. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 66. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 67. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 68. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 69. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 70. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 71. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 72. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 73. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 74. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 75. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 76. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 77. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 78. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 79. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 80. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 81. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 82. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 83. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 84. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 85. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 86. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 87. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 88. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 89. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 90. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 91. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 92. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 93. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 94. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 95. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 96. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 97. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 98. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 99. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 100. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 101. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 102. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 103. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 104. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 105. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 106. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 107. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 108. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 109. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 110. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 111. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 112. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 113. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 114. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 115. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 116. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 117. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 118. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 119. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 120. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 121. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 122. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 123. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 124. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 125. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 126. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 127. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 128. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 129. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 130. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 131. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 132. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 133. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 134. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 135. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 136. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 137. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 138. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 139. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 140. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 141. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 142. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)TABLE 143. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)TABLE 144. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)TABLE 145. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)TABLE 146. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVALTABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSISFIGURE 2. NORTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSISFIGURE 3. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 4. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 5. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 6. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 7. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 8. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 9. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 10. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 11. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 12. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 13. EUROPE RADIOPHARMACEUTICALS MARKET ANALYSISFIGURE 14. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 15. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 16. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 17. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 18. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 19. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 20. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 21. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 22. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 23. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 24. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 25. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 26. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 27. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 28. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 29. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 30. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 31. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 32. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 33. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 34. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 35. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 36. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 37. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 38. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 39. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 40. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 41. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 42. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 43. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 44. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 45. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 46. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 47. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 48. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 49. APAC RADIOPHARMACEUTICALS MARKET ANALYSISFIGURE 50. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 51. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 52. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 53. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 54. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 55. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 56. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 57. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 58. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 59. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 60. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 61. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 62. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 63. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 64. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 65. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 66. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 67. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 68. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 69. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 70. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 71. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 72. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 73. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 74. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 75. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 76. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 77. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 78. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 79. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 80. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 81. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 82. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 83. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 84. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 85. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 86. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 87. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 88. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 89. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 90. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSISFIGURE 91. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 92. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 93. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 94. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 95. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 96. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 97. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 98. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 99. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 100. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 101. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 102. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 103. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 104. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 105. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 106. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 107. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 108. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 109. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 110. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 111. MEA RADIOPHARMACEUTICALS MARKET ANALYSISFIGURE 112. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 113. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 114. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 115. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 116. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 117. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 118. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 119. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 120. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 121. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 122. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATIONFIGURE 123. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPEFIGURE 124. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASSFIGURE 125. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USEFIGURE 126. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONALFIGURE 127. KEY BUYING CRITERIA OF RADIOPHARMACEUTICALS MARKETFIGURE 128. RESEARCH PROCESS OF MRFRFIGURE 129. DRO ANALYSIS OF RADIOPHARMACEUTICALS MARKETFIGURE 130. DRIVERS IMPACT ANALYSIS: RADIOPHARMACEUTICALS MARKETFIGURE 131. RESTRAINTS IMPACT ANALYSIS: RADIOPHARMACEUTICALS MARKETFIGURE 132. SUPPLY / VALUE CHAIN: RADIOPHARMACEUTICALS MARKETFIGURE 133. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2025 (% SHARE)FIGURE 134. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)FIGURE 135. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2025 (% SHARE)FIGURE 136. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2019 TO 2035 (USD Billions)FIGURE 137. RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS, 2025 (% SHARE)FIGURE 138. RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS, 2019 TO 2035 (USD Billions)FIGURE 139. RADIOPHARMACEUTICALS MARKET, BY END USE, 2025 (% SHARE)FIGURE 140. RADIOPHARMACEUTICALS MARKET, BY END USE, 2019 TO 2035 (USD Billions)FIGURE 141. RADIOPHARMACEUTICALS MARKET, BY REGIONAL, 2025 (% SHARE)FIGURE 142. RADIOPHARMACEUTICALS MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS